Trial Profile

Prospective, randomized, multi-center, double-blind, controlled, two-period, two-treatment, crossover, adaptive enrichment phase II trial to evaluate the safety and efficacy of PD-Protec™ in peritoneal dialysis in patients with chronic renal failure

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Jun 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Jun 2017 Results from this trial published in a Zytoprotec Media Release.
17 Feb 2017 Status changed from active, no longer recruiting to completed.
14 Nov 2016 According to a Zytoprotec media release, the last patient has completed treatment in this trial.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com